Free Trial

Cyanotech Q4 2023 Earnings Report

Cyanotech EPS Results

Actual EPS
-$0.23
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cyanotech Revenue Results

Actual Revenue
$5.39 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cyanotech Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Cyanotech Earnings Headlines

22x better than Bitcoin… WITHOUT crypto
We’re on the verge of a massive paradigm shift. And it will leave millions of people behind… including you, perhaps. The legendary former hedge fund manager Larry Benedict has discovered a different way to make money from Bitcoin.
See More Cyanotech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cyanotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cyanotech and other key companies, straight to your email.

About Cyanotech

Cyanotech (NASDAQ:CYAN) Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.

View Cyanotech Profile

More Earnings Resources from MarketBeat